CA2635281A1 - Method of using guava extract and composition including guava extract - Google Patents

Method of using guava extract and composition including guava extract Download PDF

Info

Publication number
CA2635281A1
CA2635281A1 CA002635281A CA2635281A CA2635281A1 CA 2635281 A1 CA2635281 A1 CA 2635281A1 CA 002635281 A CA002635281 A CA 002635281A CA 2635281 A CA2635281 A CA 2635281A CA 2635281 A1 CA2635281 A1 CA 2635281A1
Authority
CA
Canada
Prior art keywords
composition
administering
mammal
extract
guava
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002635281A
Other languages
English (en)
French (fr)
Inventor
Fred Wehling
Mary Aldritt
Ge Ming Lui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amerilab Technologies Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2635281A1 publication Critical patent/CA2635281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/40Effervescence-generating compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Addiction (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA002635281A 2006-01-06 2007-01-05 Method of using guava extract and composition including guava extract Abandoned CA2635281A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/327,586 2006-01-06
US11/327,586 US7611739B2 (en) 2006-01-06 2006-01-06 Method of using guava extract and composition including guava extract
PCT/US2007/060157 WO2007112138A2 (en) 2006-01-06 2007-01-05 Method of using guava extract and composition including guava extract

Publications (1)

Publication Number Publication Date
CA2635281A1 true CA2635281A1 (en) 2007-10-04

Family

ID=38232997

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002635281A Abandoned CA2635281A1 (en) 2006-01-06 2007-01-05 Method of using guava extract and composition including guava extract

Country Status (13)

Country Link
US (3) US7611739B2 (enExample)
EP (1) EP1976544B1 (enExample)
JP (1) JP2009522376A (enExample)
CN (1) CN101360507B (enExample)
AT (1) ATE467420T1 (enExample)
AU (1) AU2007230860B2 (enExample)
CA (1) CA2635281A1 (enExample)
DE (1) DE602007006419D1 (enExample)
ES (1) ES2345067T3 (enExample)
PL (1) PL1976544T3 (enExample)
PT (1) PT1976544E (enExample)
RU (1) RU2405564C2 (enExample)
WO (1) WO2007112138A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20090068300A1 (en) * 2007-09-07 2009-03-12 Veripak, Inc. Pre- and post-workout formulations processes and supplement products thereby
EP2300027A1 (en) * 2008-07-10 2011-03-30 Amerilab Technologies, Inc. Method of treating migraine using guava
US20100215758A1 (en) * 2009-02-25 2010-08-26 Joar Opheim Effervescent nutritional and/or dietary supplement composition
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
WO2011133911A1 (en) * 2010-04-22 2011-10-27 Amerilab Technologies, Inc. An effervescent carrier, a method of changing the flavor of milk, and an effervescent tablet for changing the flavor of milk
US20110318468A1 (en) * 2010-06-29 2011-12-29 Aleksandre Kakhaberi Fructose-based anti-diabetic alcoholic beverage and method of making same
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
US10131084B2 (en) 2012-05-24 2018-11-20 Husky Injection Molding Systems Ltd. Method of transferring a molded article
FI129157B (en) * 2012-05-28 2021-08-13 Biohit Oyj Composition for use in reducing the incidence of or preventing severe headaches
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
BR112020021852A2 (pt) * 2018-05-02 2021-02-23 Ferring B.V. formulações farmacêuticas aperfeiçoadas
CN113841814A (zh) * 2021-05-13 2021-12-28 佳纬生物技术有限公司 一种适用于巴沙鱼和日本沼虾混养饲料及其无公害混养方法
EP4115741B1 (en) * 2021-11-16 2024-09-25 Pompadour Ibérica S.A. A beverage composition with controlled effervescence for infusion in a cold liquid

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6036746B2 (ja) * 1983-09-06 1985-08-22 備前化成株式会社 グアバ葉エキスからなる健康飲料
JPS6137731A (ja) * 1984-07-31 1986-02-22 Bizen Kasei Kk グアバ葉エキスを有効成分とする経口糖尿病薬
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
RU2097053C1 (ru) * 1994-09-26 1997-11-27 Анна Геннадьевна Пономарева Лекарственный сбор "петрович" для снятия тяги к алкоголю
JP3222021B2 (ja) 1994-09-29 2001-10-22 長谷川香料株式会社 虫歯防止剤
JPH092969A (ja) * 1995-06-20 1997-01-07 O S Kogyo Kk アレルギー疾患治療剤
JP3625900B2 (ja) 1995-06-29 2005-03-02 株式会社ヤクルト本社 腎臓疾患治療剤
JP3871370B2 (ja) * 1996-02-28 2007-01-24 株式会社ロッテ 精神安定用剤
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
US5955057A (en) * 1998-06-12 1999-09-21 Biotech Holdings Ltd. Effervescing or foaming bath shape or solid
US6171633B1 (en) * 1998-08-14 2001-01-09 Natura, Inc. Milk-based drink
JP2001039884A (ja) * 1999-08-02 2001-02-13 T Hasegawa Co Ltd 歯周病防止剤
GB9920270D0 (en) * 1999-08-26 1999-10-27 Bush Boake Allen Ltd Flavouring agent and methods for preparing and using same
US20020172738A1 (en) * 1999-09-13 2002-11-21 Young Thomas B. Alcohol sweetened and sparkling fruit ciders and method for same
JP2001226274A (ja) 2000-02-09 2001-08-21 Matsuura Yakugyo Kk リパーゼ阻害剤
CN1264978C (zh) * 2000-03-10 2006-07-19 株式会社益力多本社 α-淀粉酶活性抑制剂
JP2002255837A (ja) 2001-03-01 2002-09-11 Mikimoto Pharmaceut Co Ltd アルドースレダクターゼ阻害剤
ES2173047B1 (es) 2001-03-21 2004-01-01 Aplicaciones Farmacodinamicas Procedimiento para la obtencion de las diferentes fracciones de guayaba atomizada y su uso para el tratamiento de la diabetes mellitus tipo ii
RU2181593C1 (ru) * 2001-04-18 2002-04-27 Миронов Владимир Андреевич Микстура для дезинтоксикации организма и способ лечения алкоголизма и наркомании с использованием микстуры
KR100443264B1 (ko) 2001-06-07 2004-08-04 한국생명공학연구원 구아바로부터 얻은 단백질 타이로신 탈인산화 효소 1b 저해용 활성분획 추출물
US6824798B2 (en) * 2001-09-27 2004-11-30 J. Gregory Koenig Method of preventing veisalgia
JP2003189828A (ja) 2001-12-28 2003-07-08 Yamaguchi Chagyo:Kk 茶代用品
US6616950B2 (en) * 2002-01-14 2003-09-09 Council Of Scientific And Industrial Research Fermented herbal health drink from plant andrographis
US6811793B2 (en) * 2002-03-11 2004-11-02 Amerilab Technologies, Inc. Effervescent composition including stevia
JP2004075571A (ja) 2002-08-12 2004-03-11 Os Kogyo Kk 点鼻剤およびその製造方法
FI20021819A0 (fi) * 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
KR20030026939A (ko) 2003-01-27 2003-04-03 최미회 구아바잎을 주성분으로한 당뇨병치료용, 비만개선용,노화방지용차의 효과적인 조성물 및 이를 함유한 건강식품
JP2004267075A (ja) 2003-03-07 2004-09-30 Washi Kosan Co Ltd 過剰栄養分のエネルギー代謝を阻害する主食用米飯
CN100496561C (zh) * 2003-05-22 2009-06-10 北京大学 一种改善糖耐量和治疗糖尿病及肥胖症的药物及其制备方法
CN1245193C (zh) * 2003-05-23 2006-03-15 李森青 含有硫化丙烯辛香气味植物的发酵素、其制备方法及其用途
KR20040066768A (ko) 2004-07-07 2004-07-27 홍진경 구아바와 야콘을 이용한 당뇨치료용 조성물 및 그 제조방법

Also Published As

Publication number Publication date
EP1976544A2 (en) 2008-10-08
US20070160703A1 (en) 2007-07-12
US7611739B2 (en) 2009-11-03
WO2007112138A3 (en) 2007-11-22
ES2345067T3 (es) 2010-09-14
US7247324B1 (en) 2007-07-24
DE602007006419D1 (de) 2010-06-24
WO2007112138A2 (en) 2007-10-04
PT1976544E (pt) 2010-07-22
RU2008123267A (ru) 2010-02-20
US20070160702A1 (en) 2007-07-12
CN101360507B (zh) 2012-04-18
HK1125291A1 (en) 2009-08-07
AU2007230860B2 (en) 2012-05-31
CN101360507A (zh) 2009-02-04
EP1976544B1 (en) 2010-05-12
AU2007230860A1 (en) 2007-10-04
RU2405564C2 (ru) 2010-12-10
ATE467420T1 (de) 2010-05-15
PL1976544T3 (pl) 2010-10-29
US20080268081A1 (en) 2008-10-30
JP2009522376A (ja) 2009-06-11

Similar Documents

Publication Publication Date Title
US20080268081A1 (en) Method of using guava extract and composition including guava extract
JP2021524442A (ja) 医薬品活性成分に適した錠剤化チューインガム
US8313784B2 (en) Method of using guava extract
WO2020051054A1 (en) Cannabinoid and anesthetic gum and lozenge compositions and methods
CN108135814A (zh) 木兰树皮提取物和L-精氨酸Nα-月桂酰基乙酯对唾液菌的协同抗菌作用
CN108135876A (zh) 木兰树皮提取物和L-精氨酸Nα-月桂酰基乙酯对菌斑生物膜的协同抗菌作用
US20110229601A1 (en) Chewing gum containing low dose amounts of water soluble vitamins
US20200069638A1 (en) Cannabinoid and menthol gum and lozenge compositions and methods
JP5746454B2 (ja) 嗜好品
WO2010005438A1 (en) Method of treating migraine using guava
US20070014834A1 (en) Apparatus and methods of improved delivery of orally-administered therapeutic substances
HK1125291B (en) Method of using guava extract and composition including guava extract
MX2008008297A (en) Method of using guava extract and composition including guava extract
TWI905885B (zh) β–石竹烯之用途
US11376227B2 (en) Cannabinoid and menthol gum and lozenge compositions and methods
HK1158058B (en) Method of treating migraine using guava
HK1158058A (en) Method of treating migraine using guava
WO2024236294A1 (en) Oral product
Jhanwar et al. Chewing Gum: Confectionary To a Popular Transbuccal Dosage Form
JP2025535893A (ja) 経口製品
TW202442254A (zh) 口服產品
EP4598376A1 (en) Oral product
WO2021177942A1 (en) Cannabinoid and menthol gum and lozenge compositions and methods

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20150106